Correlation Between Inhibikase Therapeutics and Sio Gene

Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Sio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Sio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibikase Therapeutics and Sio Gene Therapies, you can compare the effects of market volatilities on Inhibikase Therapeutics and Sio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Sio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Sio Gene.

Diversification Opportunities for Inhibikase Therapeutics and Sio Gene

-0.8

Correlation Coefficient

Inhibikase Therapeutics  Sio Gene

Pay attention - limited upside

The 3 months correlation between Inhibikase and Sio is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Sio Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sio Gene Therapies and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Sio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sio Gene Therapies has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Sio Gene go up and down completely randomly.

Pair Corralation between Inhibikase Therapeutics and Sio Gene

If you would invest  182.00  in Inhibikase Therapeutics on September 2, 2024 and sell it today you would earn a total of  110.00  from holding Inhibikase Therapeutics or generate 60.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	0.79%
Values	Daily Returns

Inhibikase Therapeutics  vs.  Sio Gene Therapies

Inhibikase Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibikase Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady forward-looking signals, Inhibikase Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sio Gene Therapies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sio Gene Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sio Gene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Inhibikase Therapeutics and Sio Gene

The main advantage of trading using opposite Inhibikase Therapeutics and Sio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Sio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sio Gene will offset losses from the drop in Sio Gene's long position.

The idea behind Inhibikase Therapeutics and Sio Gene Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..